How to buy Homology Medicines stock (FIXX)

Homology Medicines is a biotechnology business based in the US. Homology Medicines shares (FIXX) are listed on the NASDAQ and all prices are listed in US Dollars. Homology Medicines employs 7 staff and has a trailing 12-month revenue of around $1.2 million.

Our top picks for where to buy Homology Medicines stock

Buy Homology Medicines stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Homology Medicines stock price (NASDAQ: FIXX)

Use our graph to track the performance of FIXX stocks over time.

Homology Medicines shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$9.90 - $17.51
50-day moving average more info button	$13.80
200-day moving average more info button	$16.10
Wall St. target price	$1.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-35.10

Is it a good time to buy Homology Medicines stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Homology Medicines financials

Revenue TTM	$1.2 million
Gross profit TTM	$-95,143,000
Return on assets TTM	-36.4%
Return on equity TTM	-90.02%
Profit margin	0%
Book value	$22.65
Market Capitalization more info button	$3 million

TTM: trailing 12 months

Homology Medicines share dividends

We're not expecting Homology Medicines to pay a dividend over the next 12 months.

Have Homology Medicines's shares ever split?

Homology Medicines's shares were split on a 1:18 basis on 24 March 2024 . So if you had owned 18 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Homology Medicines shares – just the quantity. However, indirectly, the new 1700% higher share price could have impacted the market appetite for Homology Medicines shares which in turn could have impacted Homology Medicines's share price.

Homology Medicines share price volatility

Over the last 12 months, Homology Medicines's shares have ranged in value from as little as $9.9018 up to $17.505. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Homology Medicines's is -0.107. This would suggest that Homology Medicines's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Homology Medicines has bucked the trend.

Homology Medicines overview

Homology Medicines, Inc. , a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts. .

Frequently asked questions

null
What percentage of Homology Medicines is owned by insiders or institutions?
Currently 9.29% of Homology Medicines shares are held by insiders and 46.756% by institutions. How many people work for Homology Medicines?
Latest data suggests 7 work at Homology Medicines. When does the fiscal year end for Homology Medicines?
Homology Medicines's fiscal year ends in December. Where is Homology Medicines based?
Homology Medicines's address is: One Patriots Park, Bedford, MA, United States, 01730 What is Homology Medicines's ISIN number?
Homology Medicines's international securities identification number is: US4380831077 What is Homology Medicines's CUSIP number?
Homology Medicines's Committee on Uniform Securities Identification Procedures number is: 438083107